EMA Authorised: Tacforius (tacrolimus monohydrate) — Teva B.V.

View source ↗

Summary

The EMA authorised Tacforius, tacrolimus monohydrate, by Teva B.V. for use in liver and kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Tacforius (tacrolimus monohydrate)

Snippet

Status: Authorised. Therapeutic area: Liver Transplantation;Kidney Transplantation. MAH: Teva B.V.. Decision date: 08/05/2025